Injectable corticosteroid and local anesthetic preparations: A review for radiologists

Radiology

Volumn 252, Issue 3, 2009, Pages 647-661

  MacMahon, Peter J ^a   Eustace, Stephen J ^a   Kavanagh, Eoin C ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; BUPIVACAINE; CORTICOSTEROID; DEXAMETHASONE SODIUM PHOSPHATE; LIDOCAINE; LOCAL ANESTHETIC AGENT; METHYLPREDNISOLONE ACETATE; PROCAINE; ROPIVACAINE; TRIAMCINOLONE ACETATE;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL ARTHRITIS; CARDIOTOXICITY; CARDIOVASCULAR SYSTEM; CARTILAGE CELL; CARTILAGE INJURY; CENTRAL NERVOUS SYSTEM; CHONDROLYSIS; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG CLASSIFICATION; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG FORMULATION; DRUG INDICATION; FLUSHING; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LOCAL ANESTHESIA; MEDICATION ERROR; MUSCLE DISEASE; MUSCULOSKELETAL DISEASE; NEUROTOXICITY; NONHUMAN; PAIN; PRIORITY JOURNAL; RADIOLOGIST; REVIEW; SIDE EFFECT; TENDON RUPTURE;

ADRENAL CORTEX HORMONES; ANESTHETICS, LOCAL; HUMANS; INJECTIONS; RADIOLOGY, INTERVENTIONAL;

EID: 70349267666     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2523081929     Document Type: Review

References (176)

1. Manchikanti L, Cash KA, Pampati V, McManus CD, Damron KS. Evaluation of fluoroscopically guided caudal epidural injections. Pain Physician 2004;7:81-92. (Pubitemid 38195758)
2. Robinson P, Keenan AM, Conaghan PG. Clinical effectiveness and dose response of image-guided intra-articular corticosteroid injection for hip osteoarthritis. Rheumatology (Oxford) 2007;46:285-291. (Pubitemid 46189790)
3. Ravaud P, Moulinier L, Giraudeau B, et al. Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial. Arthritis Rheum 1999;42:475-482. (Pubitemid 29136095)
4. Hochberg MC, Perlmutter DL, Hudson JI, Altman RD. Preferences in the management of osteoarthritis of the hip and knee: results of a survey of community-based rheumatologists in the United States. Arthritis Care Res 1996;9:170-176.
5. Louis LJ. Musculoskeletal ultrasound intervention: principles and advances. Radiol Clin North Am 2008;46:515-533, vi.
6. Crawford RW, Gie GA, Ling RS, Murray DW. Diagnostic value of intra-articular anaesthetic in primary osteoarthritis of the hip. J Bone Joint Surg Br 1998;80:279-281. (Pubitemid 28140371)
7. Khoury NJ, el-Khoury GY, Saltzman CL, Brandser EA. Intraarticular foot and ankle injections to identify source of pain before arthrodesis. AJR Am J Roentgenol 1996;167:669-673.
8. Hench PS, Kendall EC, et al. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin Proc 1949;24:181-197.
9. Schramm R, Thorlacius H. Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids. Inflamm Res 2004;53:644-652. (Pubitemid 40174539)
10. Malemud CJ. Cytokines as therapeutic targets for osteoarthritis. BioDrugs 2004;18:23-35.
11. Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998;94:557-572. (Pubitemid 28269054)
12. Eymontt MJ, Gordon GV, Schumacher HR, Hansell JR. The effects on synovial permeability and synovial fluid leukocyte counts in symptomatic osteoarthritis after intraarticular corticosteroid administration. J Rheumatol 1982;9:198-203.
13. Buckingham JC, John CD, Solito E, et al. Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. Ann N Y Acad Sci 2006;1088:396-409.
14. D'Acquisto F, Paschalidis N, Raza K, Buckley CD, Flower RJ, Perretti M. Glucocorticoid treatment inhibits annexin-1 expression in rheumatoid arthritis CD4+ T cells. Rheumatology (Oxford) 2008;47:636-639. (Pubitemid 351619203)
15. Hollander JL. The local effects of compound F (hydrocortisone) injected into joints. Bull Rheum Dis 1951;2:3-4.
16. Hollander JL. Intra-articular corticosteroid therapy. Am Pract Dig Treat 1961;12:190-193.
17. Brown EM Jr, Frain JB, Udell L, Hollander JL. Locally administered hydrocortisone in the rheumatic diseases; a summary of its use in 547 patients. Am J Med 1953;15:656-665.
18. Hollander JL, Brown EM Jr, Jessar RA, Brown CY. Hydrocortisone and cortisone injected into arthritic joints: comparative effects of and use of hydrocortisone as a local antiarthritic agent. JAMA 1951;147:1629-1635.
19. Hollander JL, Jessar RA, Brown EM Jr. Intra-synovial corticosteroid therapy: a decade of use. Bull Rheum Dis 1961;11:239-240.
20. Wright JM, Cowper JJ, Page Thomas DP, Knight CG. The hydrolysis of cortisol 21-esters by a homogenate of inflamed rabbit synovium and by rheumatoid synovial fluid. Clin Exp Rheumatol 1983;1:137-141.
21. Blankenbaker DG, De Smet AA, Stanczak JD, Fine JP. Lumbar radiculopathy: treatment with selective lumbar nerve blocks - comparison of effectiveness of triamcinolone and betamethasone injectable suspensions. Radiology 2005;237:738-741.
22. Stanczak J, Blankenbaker DG, De Smet AA, Fine J. Efficacy of epidural injections of Kenalog and Celestone in the treatment of lower back pain. AJR Am J Roentgenol 2003;181:1255-1258. (Pubitemid 37296399)
23. Tiso RL, Cutler T, Catania JA, Whalen K. Adverse central nervous system sequelae after selective transforaminal block: the role of corticosteroids. Spine J 2004;4:468-474. (Pubitemid 38986988)
24. Benzon HT, Chew TL, McCarthy RJ, Benzon HA, Walega DR. Comparison of the particle sizes of different steroids and the effect of dilution: a review of the relative neurotoxicities of the steroids. Anesthesiology 2007;106:331-338.
25. Derby R, Lee SH, Date ES, Lee JH, Lee CH. Size and aggregation of corticosteroids used for epidural injections. Pain Med 2008;9:227-234. (Pubitemid 351285418)
26. Francis BA, Chang EL, Haik BG. Particle size and drug interactions of injectable corticosteroids used in ophthalmic practice. Ophthalmology 1996;103:1884-1888.
27. Blyth T, Hunter JA, Stirling A. Pain relief in the rheumatoid knee after steroid injection: a single-blind comparison of hydrocortisone succinate, and triamcinolone acetonide or hexacetonide. Br J Rheumatol 1994;33:461-463. (Pubitemid 24153970)
28. Ostergaard M, Stoltenberg M, Gideon P, Sorensen K, Henriksen O, Lorenzen I. Changes in synovial membrane and joint effusion volumes after intraarticular methylprednisolone: quantitative assessment of inflammatory and destructive changes in arthritis by MRI. J Rheumatol 1996;23:1151-1161. (Pubitemid 26240578)
29. Bird HA, Ring EF, Bacon PA. A thermographic and clinical comparison of three intra-articular steroid preparations in rheumatoid arthritis. Ann Rheum Dis 1979;38:36-39.
30. Saini JS, Gupta A, Pandey SK, Gupta V, Gupta P. Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis. Acta Ophthalmol Scand 1999;77:515-518. (Pubitemid 29476366)
31. Becker WF. Hydrocortisone therapy in ganglia. Ind Med Surg 1953;22:555-557.
32. O'Donnell J. Adverse effects of corticosteroids. J Pharm Pract 1989;2:256-266.
33. Kondo T, Kitazawa R, Yamaguchi A, Kitazawa S. Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels. J Cell Biochem 2008;103:335-345.
34. Aspenberg P. Drugs and fracture repair. Acta Orthop 2005;76:741-748.
35. Pountos I, Georgouli T, Blokhuis TJ, Pape HC, Giannoudis PV. Pharmacological agents and impairment of fracture healing: what is the evidence? Injury 2008;39:384-394.
36. Padeh S, Passwell JH. Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 1998;41:1210-1214. (Pubitemid 28313422)
37. Ostergaard M, Halberg P. Intra-articular corticosteroids in arthritic disease: a guide to treatment. BioDrugs 1998;9:95-103.
38. van de Putte LBA, Furst DE, Williams HJ, van Riel PLCM, eds. Therapy of systemic rheumatic disorders. New York, NY: Marcel Dekker, 1997.
39. Thumboo J, O'Duffy JD. A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium. Arthritis Rheum 1998;41:736-739. (Pubitemid 28214994)
40. Gray RG, Tenenbaum J, Gottlieb NL. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum 1981;10:231-254. (Pubitemid 11082400)
41. Friedman DM, Moore ME. The efficacy of intraarticular steroids in osteoarthritis: a double-blind study. J Rheumatol 1980;7:850-856. (Pubitemid 11181502)
42. Berger RG, Yount WJ. Immediate "steroid flare" from intraarticular triamcinolone hexacetonide injection: case report and review of the literature. Arthritis Rheum 1990;33:1284-1286.
43. Kendall PH. Local corticosteroid injection therapy. III. Ann Phys Med 1963;7:31-38.
44. Mankin HJ, Conger KA. The acute effects of intra-articular hydrocortisone on articular cartilage in rabbits. J Bone Joint Surg Am 1966;48:1383-1388.
45. Behrens F, Shepard N, Mitchell N. Alterations of rabbit articular cartilage by intra-articular injections of glucocorticoids. J Bone Joint Surg Am 1975;57:70-76.
46. Pelletier JP, Mineau F, Raynauld JP, Woessner JF Jr, Gunja-Smith Z, Martel-Pelletier J. Intraarticular injections with methylprednisolone acetate reduce osteoarthritic lesions in parallel with chondrocyte stromelysin synthesis in experimental osteoarthritis. Arthritis Rheum 1994;37:414-423. (Pubitemid 24093634)
47. Celeste C, Ionescu M, Robin Poole A, Laverty S. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid. J Orthop Res 2005;23:602-610. (Pubitemid 40631332)
48. Balch HW, Gibson JM, El-Ghobarey AF, Bain LS, Lynch MP. Repeated corticosteroid injections into knee joints. Rheumatol Rehabil 1977;16:137-140.
49. Raynauld JP, Buckland-Wright C, Ward R, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2003;48:370-377. (Pubitemid 36278004)
50. Cassidy JT, Bole GG. Cutaneous atrophy secondary to intra-articular corticosteroid administration. Ann Intern Med 1966;65:1008-1018.
51. DiStefano V, Nixon JE. Steroid-induced skin changes following local injection. Clin Orthop Relat Res 1972;87:254-256.
52. Place VA, Velazquez JG, Burdick KH. Precise evaluation of topically applied corticosteroid potency: modification of the Stoughton-McKenzie assay. Arch Dermatol 1970;101:531-537.
53. Newman BA, Feldman FF. The topical and systemic use of cortisone in dermatology. Calif Med 1951;75:324-331.
54. Basadonna PT, Rucco V, Gasparini D, Onorato A. Plantar fat pad atrophy after corticosteroid injection for an interdigital neuroma: a case report. Am J Phys Med Rehabil 1999;78:283-285. (Pubitemid 29227177)
55. Iuel J, Kryger J. Local cutaneous atrophy following corticosteroid injection. Acta Rheumatol Scand 1965;11:137-144.
56. Rogojan C, Hetland ML. Depigmentation: a rare side effect to intra-articular glucocorticoid treatment. Clin Rheumatol 2004;23:373-375. (Pubitemid 39193801)
57. Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol 1975;111:40-48.
58. Jacobs MB. Local subcutaneous atrophy after corticosteroid injection. Postgrad Med 1986;80:159-160. (Pubitemid 16008587)
59. Lund IM, Donde R, Knudsen EA. Persistent local cutaneous atrophy following corticosteroid injection for tendinitis. Rheumatol Rehabil 1979;18:91-93. (Pubitemid 9194860)
60. Schetman D, Hambrick GW Jr, Wilson CE. Cutaneous changes following local injection of triamcinolone. Arch Dermatol 1963;88:820-828.
61. Shumaker PR, Rao J, Goldman MP. Treatment of local, persistent cutaneous atrophy following corticosteroid injection with normal saline infiltration. Dermatol Surg 2005;31:1340-1343. (Pubitemid 41587047)
62. Wong ME, Hollinger JO, Pinero GJ. Integrated processes responsible for soft tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:475-492. (Pubitemid 126813064)
63. Clark SC, Jones MW, Choudhury RR, Smith E. Bilateral patellar tendon rupture secondary to repeated local steroid injections. J Accid Emerg Med 1995;12:300-301. (Pubitemid 26016612)
64. Ford LT, DeBender J. Tendon rupture after local steroid injection. South Med J 1979;72:827-830. (Pubitemid 9244138)
65. Chen SK, Lu CC, Chou PH, Guo LY, Wu WL. Patellar tendon ruptures in weight lifters after local steroid injections. Arch Orthop Trauma Surg 2009;129:369-372.
66. Scutt N, Rolf CG, Scutt A. Glucocorticoids inhibit tenocyte proliferation and tendon progenitor cell recruitment. J Orthop Res 2006;24:173-182. (Pubitemid 43773028)
67. Haraldsson BT, Langberg H, Aagaard P, et al. Corticosteroids reduce the tensile strength of isolated collagen fascicles. Am J Sports Med 2006;34:1992-1997. (Pubitemid 44704255)
68. Gottlieb NL, Riskin WG. Complications of local corticosteroid injections. JAMA 1980;243:1547-1548.
69. Duclos M, Guinot M, Colsy M, et al. High risk of adrenal insufficiency after a single articular steroid injection in athletes. Med Sci Sports Exerc 2007;39:1036-1043. (Pubitemid 47014130)
70. Younes M, Neffati F, Touzi M, et al. Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and non-diabetic patients. Joint Bone Spine 2007;74:472-476. (Pubitemid 47588980)
71. Weitoft T, Larsson A, Ronnblom L. Serum levels of sex steroid hormones and matrix metalloproteinases after intra-articular glucocorticoid treatment in female patients with rheumatoid arthritis. Ann Rheum Dis 2008;67:422-424. (Pubitemid 351281282)
72. Lazarevic MB, Skosey JL, Djordjevic-Denic G, Swedler WI, Zgradic I, Myones BL. Reduction of cortisol levels after single intraarticular and intramuscular steroid injection. Am J Med 1995;99:370-373.
73. Dorsey MJ, Cohen LE, Phipatanakul W, Denufrio D, Schneider LC. Assessment of adrenal suppression in children with asthma treated with inhaled corticosteroids: use of dehydroepiandrosterone sulfate as a screening test. Ann Allergy Asthma Immunol 2006;97:182-186. (Pubitemid 44272583)
74. Christensson C, Thoren A, Lindberg B. Safety of inhaled budesonide: clinical manifestations of systemic corticosteroid-related adverse effects. Drug Saf 2008;31:965-988.
75. Habib GS, Bashir M, Jabbour A. Increased blood glucose levels following intra-articular injection of methylprednisolone acetate in patients with controlled diabetes and symptomatic osteoarthritis of the knee. Ann Rheum Dis 2008;67:1790-1791.
76. Baumgarten KM, Gerlach D, Boyer MI. Corticosteroid injection in diabetic patients with trigger finger: a prospective, randomized, controlled double-blinded study. J Bone Joint Surg Am 2007;89:2604-2611. (Pubitemid 350230613)
77. Wang AA, Hutchinson DT. The effect of corticosteroid injection for trigger finger on blood glucose level in diabetic patients. J Hand Surg [Am] 2006;31:979-981.
78. Pattrick M, Doherty M. Facial flushing after intra-articular injection of steroid. Br Med J (Clin Res Ed) 1987;295:1380. (Pubitemid 17163371)
79. Everett CR, Baskin MN, Speech D, Novoseletsky D, Patel R. Flushing as a side effect following lumbar transforaminal epidural steroid injection. Pain Physician 2004;7:427-429. (Pubitemid 39562099)
80. DeSio JM, Kahn CH, Warfield CA. Facial flushing and/or generalized erythema after epidural steroid injection. Anesth Analg 1995;80:617-619.
81. Rathmell JP, Aprill C, Bogduk N. Cervical transforaminal injection of steroids. Anesthesiology 2004;100:1595-1600.
82. Rosenkranz M, Grzyska U, Niesen W, et al. Anterior spinal artery syndrome following periradicular cervical nerve root therapy. J Neurol 2004;251:229-231. (Pubitemid 38221641)
83. Brouwers PJ, Kottink EJ, Simon MA, Prevo RL. A cervical anterior spinal artery syndrome after diagnostic blockade of the right C6-nerve root. Pain 2001;91:397-399. (Pubitemid 32241162)
84. Baker R, Dreyfuss P, Mercer S, Bogduk N. Cervical transforaminal injection of corticosteroids into a radicular artery: a possible mechanism for spinal cord injury. Pain 2003;103:211-215. (Pubitemid 36579101)
85. Rozin L, Rozin R, Koehler SA, et al. Death during transforaminal epidural steroid nerve root block (C7) due to perforation of the left vertebral artery. Am J Forensic Med Pathol 2003;24:351-355.
86. Ruppen W, Hugli R, Reuss S, Aeschbach A, Urwyler A. Neurological symptoms after cervical transforaminal injection with steroids in a patient with hypoplasia of the vertebral artery. Acta Anaesthesiol Scand 2008;52:165-166.
87. Muro K, O'Shaughnessy B, Ganju A. Infarction of the cervical spinal cord following multilevel transforaminal epidural steroid injection: case report and review of the literature. J Spinal Cord Med 2007;30:385-388.
88. Suresh S, Berman J, Connell DA. Cerebellar and brainstem infarction as a complication of CT-guided transforaminal cervical nerve root block. Skeletal Radiol 2007;36:449-452. (Pubitemid 46502134)
89. Ludwig MA, Burns SP. Spinal cord infarction following cervical transforaminal epidural injection: a case report. Spine 2005;30:E266-E268.
90. Cicala RS, Westbrook L, Angel JJ. Side effects and complications of cervical epidural steroid injections. J Pain Symptom Manage 1989;4:64-66. (Pubitemid 19153266)
91. Houten JK, Errico TJ. Paraplegia after lumbosacral nerve root block: report of three cases. Spine J 2002;2:70-75.
92. McMillan MR, Crumpton C. Cortical blindness and neurologic injury complicating cervical transforaminal injection for cervical radiculopathy. Anesthesiology 2003;99:509-511. (Pubitemid 36909581)
93. Hurst RW, Rosenwasser RH. Interventional neuroradiology. Boca Raton, Fla: CRC, 2007.
94. Worthington-Kirsch R, Fueredi G, Goodwin S, et al. Polyvinyl alcohol particle size for uterine artery embolization [letter]. Radiology 2001;218:605. (Pubitemid 32121086)
95. Rapp JH, Hollenbeck K, Pan XM. An experimental model of lacunar infarction: embolization of microthrombi. J Vasc Surg 2008;48:196-200.
96. Rapp JH, Pan XM, Yu B, et al. Cerebral ischemia and infarction from atheroemboli <100 micron in size. Stroke 2003;34:1976-1980. (Pubitemid 36944793)
97. Liapi E, Georgiades CC, Hong K, Geschwind JF. Transcatheter arterial chemoembolization: current technique and future promise. Tech Vasc Interv Radiol 2007;10:2-11. (Pubitemid 350008078)
98. Stampfl S, Stampfl U, Rehnitz C, et al. Experimental evaluation of early and long-term effects of microparticle embolization in two different mini-pig models. I. Kidney. Cardiovasc Intervent Radiol 2007;30:257-267.
99. Scanlon GC, Moeller-Bertram T, Romanowsky SM, Wallace MS. Cervical transforaminal epidural steroid injections: more dangerous than we think? Spine 2007;32:1249-1256.
100. Huntoon MA. Anatomy of the cervical intervertebral foramina: vulnerable arteries and ischemic neurologic injuries after transforaminal epidural injections. Pain 2005;117:104-111.
101. Ellis PP. Occlusion of the central retinal artery after retrobulbar corticosteroid injection. Am J Ophthalmol 1978;85:352-356. (Pubitemid 8313836)
102. Wilson RS, McGrew RN, White HJ. Bilateral retinal artery and choriocapillaris occlusion following the injection of long-acting corticosteroid suspensions in combination with other drugs. II. Animal experimental studies. Ophthalmology 1978;85:975-985.
103. Gupta V, Sharma SC, Gupta A, Dogra MR. Retinal and choroidal microvascular embolization with methylprednisolone. Retina 2002;22:382-386. (Pubitemid 36150611)
104. Moshfeghi DM, Lowder CY, Roth DB, Kaiser PK. Retinal and choroidal vascular occlusion after posterior sub-tenon triamcinolone injection. Am J Ophthalmol 2002;134:132-134.
105. Okubadejo GO, Talcott MR, Schmidt RE, et al. Perils of intravascular methylprednisolone injection into the vertebral artery: an animal study. J Bone Joint Surg Am 2008;90:1932-1938.
106. Wybier M. Transforaminal epidural corticosteroid injections and spinal cord infarction. Joint Bone Spine 2008;75:523-525.
107. Manchikanti L. Role of neuraxial steroids in interventional pain management. Pain Physician 2002;5:182-199. (Pubitemid 34546132)
108. Craig DB, Habib GG. Flaccid paraparesis following obstetrical epidural anesthesia: possible role of benzyl alcohol. Anesth Analg 1977;56:219-221.
109. Bagshawe KD, Magrath IT, Golding PR. Intrathecal methotrexate. Lancet 1969;2:1258.
110. Benzon HT, Gissen AJ, Strichartz GR, Avram MJ, Covino BG. The effect of polyethylene glycol on mammalian nerve impulses. Anesth Analg 1987;66:553-559.
111. Ray CE. Pain management in interventional radiology. Cambridge, England: Cambridge University Press, 2008.
112. Spaccarelli KC. Lumbar and caudal epidural corticosteroid injections. Mayo Clin Proc 1996;71:169-178.
113. Dreyfuss P, Baker R, Bogduk N. Comparative effectiveness of cervical transforaminal injections with particulate and nonparticulate corticosteroid preparations for cervical radicular pain. Pain Med 2006;7:237-242. (Pubitemid 43676668)
114. Mayson K, Lennox P, Anserimo M, Forster BB. Canadian radiology residents' knowledge of sedation and analgesia: a Webbased survey. Can Assoc Radiol J 2006;57:35-42. (Pubitemid 43793311)
115. Hildebrand I. The history of local anaesthetic drugs. Can Serv Med J 1957;13:393-396.
116. Holmdahl MH. Xylocain (lidocaine, lignocaine): its discovery and Gordh's contribution to its clinical use. Acta Anaesthesiol Scand Suppl 1998;113:8-12. (Pubitemid 128706688)
117. Cox B, Durieux ME, Marcus MA. Toxicity of local anaesthetics. Best Pract Res Clin Anaesthesiol 2003;17:111-136.
118. Niemi G. Advantages and disadvantages of adrenaline in regional anaesthesia. Best Pract Res Clin Anaesthesiol 2005;19:229-245. (Pubitemid 40585279)
119. Brau ME, Vogel W, Hempelmann G. Fundamental properties of local anesthetics: half-maximal blocking concentrations for tonic block of Na+ and K+ channels in peripheral nerve. Anesth Analg 1998;87:885-889. (Pubitemid 28455488)
120. Camorcia M, Capogna G, Columb MO. Estimation of the minimum motor blocking potency ratio for intrathecal bupivacaine and lidocaine. Int J Obstet Anesth 2008;17:223-227.
121. Ruetsch YA, Boni T, Borgeat A. From cocaine to ropivacaine: the history of local anesthetic drugs. Curr Top Med Chem 2001;1:175-182.
122. Krunic AL, Wang LC, Soltani K, Weitzul S, Taylor RS. Digital anesthesia with epinephrine: an old myth revisited. J Am Acad Dermatol 2004;51:755-759. (Pubitemid 39516890)
123. Manchikanti L, Singh V, Falco FJ, Cash KA, Pampati V. Lumbar facet joint nerve blocks in managing chronic facet joint pain: 1-year follow-up of a randomized, double-blind controlled trial - clinical trial NCT00355914. Pain Physician 2008;11:121-132. (Pubitemid 351546225)
124. Hambly N, Fitzpatrick P, MacMahon P, Eustace S. Rotator cuff impingement: correlation between findings on MRI and outcome after fluoroscopically guided subacromial bursography and steroid injection. AJR Am J Roentgenol 2007;189:1179-1184. (Pubitemid 350033013)
125. Arner S, Lindblom U, Meyerson BA, Molander C. Prolonged relief of neuralgia after regional anesthetic blocks: a call for further experimental and systematic clinical studies. Pain 1990;43:287-297.
126. Hayashi N, Weinstein JN, Meller ST, Lee HM, Spratt KF, Gebhart GF. The effect of epidural injection of betamethasone or bupivacaine in a rat model of lumbar radiculopathy. Spine 1998;23:877-885. (Pubitemid 28188915)
127. Benzon HT. Epidural steroid injections for low back pain and lumbosacral radiculopathy. Pain 1986;24:277-295. (Pubitemid 16162631)
128. Lavoie PA, Khazen T, Filion PR. Mechanisms of the inhibition of fast axonal transport by local anesthetics. Neuropharmacology 1989;28:175-181. (Pubitemid 19056226)
129. Bisby MA. Inhibition of axonal transport in nerves chronically treated with local anesthetics. Exp Neurol 1975;47:481-489.
130. Katz WA, Rothenberg R. Section 3: the nature of pain - pathophysiology. J Clin Rheumatol 2005;11(suppl 2):S11-S15.
131. Melzack R, Coderre TJ, Katz J, Vaccarino AL. Central neuroplasticity and pathological pain. Ann N Y Acad Sci 2001;933:157-174.
132. Cassuto J, Sinclair R, Bonderovic M. Antiinflammatory properties of local anesthetics and their present and potential clinical implications. Acta Anaesthesiol Scand 2006;50:265-282.
133. Ban M, Hattori M. Delayed hypersensitivity due to epidural block with ropivacaine. BMJ 2005;330:229. (Pubitemid 40188073)
134. Duque S, Fernandez L. Delayed-type hypersensitivity to amide local anesthetics. Allergol Immunopathol (Madr) 2004;32:233-234. (Pubitemid 39056168)
135. Goulet JP, Perusse R, Turcotte JY. Contraindications to vasoconstrictors in dentistry. III. Pharmacologic interactions. Oral Surg Oral Med Oral Pathol 1992;74:692-697.
136. Karaoglu S, Dogru K, Kabak S, Inan M, Halici M. Effects of epinephrine in local anesthetic mixtures on hemodynamics and view quality during knee arthroscopy. Knee Surg Sports Traumatol Arthrosc 2002;10:226-228.
137. Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med 2004;29:564-575; discussion 524.
138. Tucker GT, Mather LE. Absorption and disposition of local anesthetics: pharmacokinetics. In: Cousins MJ, Bridenbaugh PO, eds. Neural blockade in clinical anesthesia and management of pain. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 1988.
139. Scott DB. "Maximum recommended doses" of local anaesthetic drugs. Br J Anaesth 1989;63:373-374.
140. Leone S, Di Cianni S, Casati A, Fanelli G. Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine. Acta Biomed 2008;79:92-105.
141. Liu PL, Feldman HS, Giasi R, Patterson MK, Covino BG. Comparative CNS toxicity of lidocaine, etidocaine, bupivacaine, and tetracaine in awake dogs following rapid intravenous administration. Anesth Analg 1983;62:375-379. (Pubitemid 13161142)
142. Groban L. Central nervous system and cardiac effects from long-acting amide local anesthetic toxicity in the intact animal model. Reg Anesth Pain Med 2003;28:3-11. (Pubitemid 36176681)
143. Selander D, Sjovall J, Tucker G. CNS toxicity of ropivacaine. Anaesth Intensive Care 1999;27:320-322.
144. Gristwood RW. Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaine. Drug Saf 2002;25:153-163.
145. Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology 2006;105:217-218. (Pubitemid 44305211)
146. Corman SL, Skledar SJ. Use of lipid emulsion to reverse local anesthetic-induced toxicity. Ann Pharmacother 2007;41:1873-1877.
147. Guidelines for the management of severe local anaesthetic toxicity. The Association of Anaesthetists of Great Britain and Ireland. http://www.aagbi.org/ publications/guidelines/docs/latoxicity07.pdf. Published 2007. Accessed [month, day, year].
148. Zink W, Sinner B, Zausig Y, Graf BM. Myotoxicity of local anaesthetics: experimental myth or clinical truth? [in German]. Anaesthesist 2007;56:118-127.
149. Zink W, Graf BM. Local anesthetic myotoxicity. Reg Anesth Pain Med 2004;29:333-340.
150. Brun A. Effect of procaine, carbocain and xylocaine on cutaneous muscle in rabbits and mice. Acta Anaesthesiol Scand 1959;3:59-73.
151. Hogan Q, Dotson R, Erickson S, Kettler R, Hogan K. Local anesthetic myotoxicity: a case and review. Anesthesiology 1994;80:942-947. (Pubitemid 24128960)
152. Foster AH, Carlson BM. Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Anesth Analg 1980;59:727-736.
153. Benoit PW, Belt WD. Destruction and regeneration of skeletal muscle after treatment with a local anaesthetic, bupivacaine (Marcaine). J Anat 1970;107:547-556.
154. Yagiela JA, Benoit PW, Buoncristiani RD, Peters MP, Fort NF. Comparison of myotoxic effects of lidocaine with epinephrine in rats and humans. Anesth Analg 1981;60:471-480.
155. Gomez-Arnau JI, Yanguela J, Gonzalez A, et al. Anaesthesia-related diplopia after cataract surgery. Br J Anaesth 2003;90:189-193.
156. Sadeh M, Czyewski K, Stern LZ. Chronic myopathy induced by repeated bupivacaine injections. J Neurol Sci 1985;67:229-238. (Pubitemid 15130765)
157. Chu CR, Izzo NJ, Papas NE, Fu FH. In vitro exposure to 0.5% bupivacaine is cytotoxic to bovine articular chondrocytes. Arthroscopy 2006;22:693-699.
158. Chu CR, Izzo NJ, Coyle CH, Papas NE, Logar A. The in vitro effects of bupivacaine on articular chondrocytes. J Bone Joint Surg Br 2008;90:814-820. (Pubitemid 351859815)
159. Karpie JC, Chu CR. Lidocaine exhibits dose- and time-dependent cytotoxic effects on bovine articular chondrocytes in vitro. Am J Sports Med 2007;35:1621-1627.
160. Piper SL, Kim HT. Comparison of ropivacaine and bupivacaine toxicity in human articular chondrocytes. J Bone Joint Surg Am 2008;90:986-991.
161. Dragoo JL, Korotkova T, Kanwar R, Wood B. The effect of local anesthetics administered via pain pump on chondrocyte viability. Am J Sports Med 2008;36:1484-1488. (Pubitemid 352019488)
162. Kamath R, Strichartz G, Rosenthal D. Cartilage toxicity from local anesthetics. Skeletal Radiol 2008;37:871-873.
163. Petty DH, Jazrawi LM, Estrada LS, Andrews JR. Glenohumeral chondrolysis after shoulder arthroscopy: case reports and review of the literature. Am J Sports Med 2004;32:509-515. (Pubitemid 38235525)
164. Debruyne D, Moulin MA, Carmes C, Beguin JA, Locker B. Monitoring serum bupivacaine levels during arthroscopy. Eur J Clin Pharmacol 1985;27:733-735. (Pubitemid 15167100)
165. Kaeding CC, Hill JA, Katz J, Benson L. Bupivacaine use after knee arthroscopy: pharmacokinetics and pain control study. Arthroscopy 1990;6:33-39. (Pubitemid 20140781)
166. Park CJ, Park SA, Yoon TG, Lee SJ, Yum KW, Kim HJ. Bupivacaine induces apoptosis via ROS in the Schwann cell line. J Dent Res 2005;84:852-857.
167. Tung JT, Venta PJ, Caron JP. Inducible nitric oxide expression in equine articular chondrocytes: effects of antiinflammatory compounds. Osteoarthritis Cartilage 2002;10:5-12.
168. Sisk AL. Vasoconstrictors in local anesthesia for dentistry. Anesth Prog 1992;39:187-193.
169. Cederholm I, Akerman B, Evers H. Local analgesic and vascular effects of intradermal ropivacaine and bupivacaine in various concentrations with and without addition of adrenaline in man. Acta Anaesthesiol Scand 1994;38:322-327. (Pubitemid 24156126)
170. Weber A, Fournier R, Van Gessel E, Riand N, Gamulin Z. Epinephrine does not prolong the analgesia of 20 mL ropivacaine 0.5% or 0.2% in a femoral three-in-one block. Anesth Analg 2001;93:1327-1331. (Pubitemid 33021043)
171. Oliveira NE, Lima Filho NS, Lima EG, Vasquez EC. Effects of regional anesthesia with ropivacaine on arterial pressure and heart rate in healthy subjects. Eur J Oral Sci 2006;114:27-32.
172. Kopacz DJ, Carpenter RL, Mackey DC. Effect of ropivacaine on cutaneous capillary blood flow in pigs. Anesthesiology 1989;71:69-74.
173. Iida H, Watanabe Y, Dohi S, Ishiyama T. Direct effects of ropivacaine and bupivacaine on spinal pial vessels in canine. Assessment with closed spinal window technique. Anesthesiology 1997;87:75-81.
174. Ishiyama T, Dohi S, Iida H, Watanabe Y. The effects of topical and intravenous ropivacaine on canine pial microcirculation. Anesth Analg 1997;85:75-81. (Pubitemid 27342279)
175. Timponi CF, Oliveira NE, Arruda RM, Meyrelles SS, Vasquez EC. Effects of the local anaesthetic ropivacaine on vascular reactivity in the mouse perfused mesenteric arteries. Basic Clin Pharmacol Toxicol 2006;98:518-520.
176. Dahl JB, Simonsen L, Mogensen T, Henriksen JH, Kehlet H. The effect of 0.5% ropivacaine on epidural blood flow. Acta Anaesthesiol Scand 1990;34:308-310. (Pubitemid 20247527)